Skip to main content
. 2023 Mar 30;91(1):89–98. doi: 10.1159/000530431

Table 1.

Comparison of CBC data at presentation in patients with myeloid proliferations associated with DS

ML-DS TAM Significance (p)
WBC, k/µL 7.4 27.8 <0.05
Hemoglobin, g/dL 9.8 14.0 <0.05
MCV, fL 89.1 107.5 <0.05
Platelet count, k/µL 53.3 177 <0.05

ML-DS, myeloid leukemia associated with DS; TAM, transient abnormal myelopoiesis.